BBCR Speaking Engagements and Publications 2010-Aug 2012

August 2012: Candida Fratazzi MD: Chapter author: Clinical Development Strategy: Nuts and Bolts. In Vaccinology: Principles and Practice, edited by John Morrow, Nadeem Sheikh, Clint Schmidt and Huw Davies. Published by Wiley-Blackwell.

http://www.wiley.com/WileyCDA/WileyTitle/productCd-1405185740.html

June 2012: Candida Fratazzi MD, organizer and moderator, session: “Challenges in Clinical Trials for Small Patient population”.

Bio International Conference; Boston MA

http://bostonclinicalresearch.com/challenges-in-clinical-trial-for-small-patient-populations

June 2012: Candida Fratazzi MD, invited speaker: 

Systems Biology into the Clinic: design-centered trial for effective, cost-efficient clinical development; session: “Using Systems Biology to “Fast-Track” Development and Approval of Novel Therapeutics and Diagnostics.”

Bio International Conference; Boston MA

http://bostonclinicalresearch.com/bio-2012

June 2012: Candida Fratazzi MD, interview

Bio International Conference; Boston MA

Interview Candida Fratazzi from BIO on Vimeo.

April 2012: Candida Fratazzi MD, invited speaker: “Strategic Clinical Innovation”; session: “The Rising Interest in the Rare Disease Model Could Have a Critically Important Role into Biomarker’s Implementation for Stratified Medicine.”

ACRP 2012 Global; Houston Texas

http://bostonclinicalresearch.com/acrp-2012-global-conference-and-exhibition

November 2011: Candida Fratazzi MD, invited speaker:” Current Trends and Best Practices for Data and Safety Monitoring Board: The Focus Group”.

Massachusetts Biotechnology Council; Boston MA

http://bostonclinicalresearch.com/dsmb-focus-group

June 2011: Candida Fratazzi MD, organizer and moderator, session: “Rare Diseases Experience as a Model to Critically Affect Innovation in Biomarker Strategy and precision Medicine”.

Bio International Conference; Washington DC

http://bostonclinicalresearch.com/bbcr-bio-convention

December 2010: Candida Fratazzi MD, Invited Peer-Reviewer

Biologics: Target & Therapy; Biosimilars; Drug Design, Development and Therapy; Clinical Interventions in Aging.

Dove Medical Press.

www.dovepress.com

December 2010:  Candida Fratazzi MD, Invited Speaker

Conference: “Pharmaceutical Research & Risk-Europe” – London UK

www.pharmaresearchrisk.co.uk

November 2010: Candida Fratazzi MD, Attended Training

“Final FDA Rule on Investigational New Drug (IND) safety reporting.”

www.diahome.org

November 2010: Candida Fratazzi MD, Invited Panelist: Healthcare session

Conference: 3rd Annual WMBAA

Boston University, MA, USA

November 2010: Candida Fratazzi MD, Attended Training

“Final FDA Rule on Investigational New Drug (IND) safety reporting.”

www.diahome.org

November 2010: Candida Fratazzi MD, Invited Panelist: Healthcare session

Conference: 3rd Annual WMBAA

Boston University, MA, USA

August 2010: Candida Fratazzi MD, Invited Speaker, Round Table: “Orphan Drug Challenges and Payoffs”.

Gerson Lehman Group- New York, NY

May 2010: Candida Fratazzi MD, Invited Speaker, “Current Trend and Best Practices for Data and Safety Monitoring Board” 

Mass Biotech Council, MA, USA

 www.massbio.org

You Might Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *